首页 > 最新文献

Annales De Dermatologie Et De Venereologie最新文献

英文 中文
Dual efficacy of upadacitinib in a patient with concomitant severe atopic dermatitis and alopecia areata upadacitinib治疗伴有严重特应性皮炎和斑秃的双重疗效
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.03.010
B. Walls, Z. Reguiai
{"title":"Dual efficacy of upadacitinib in a patient with concomitant severe atopic dermatitis and alopecia areata","authors":"B. Walls, Z. Reguiai","doi":"10.1016/j.annder.2023.03.010","DOIUrl":"10.1016/j.annder.2023.03.010","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9699129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reticulate skin pigmentation disorders: A morphologic approach. The concept of reticulate disorders of keratinization 网状皮肤色素沉着障碍:形态学方法。网状角化障碍的概念
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.03.013
C. Dieudonné, D. Lipsker
{"title":"Reticulate skin pigmentation disorders: A morphologic approach. The concept of reticulate disorders of keratinization","authors":"C. Dieudonné, D. Lipsker","doi":"10.1016/j.annder.2023.03.013","DOIUrl":"10.1016/j.annder.2023.03.013","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9823300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An uncommon case of epidermolysis bullosa acquisita associated with systemic sclerosis 一例罕见的大疱性表皮松解伴系统性硬化症
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.003
C. Labonne, D. Boutin, S. Baali, P. Roblot, E. Frouin, O. Renaud, E. Hainaut, M. Masson Regnault
{"title":"An uncommon case of epidermolysis bullosa acquisita associated with systemic sclerosis","authors":"C. Labonne, D. Boutin, S. Baali, P. Roblot, E. Frouin, O. Renaud, E. Hainaut, M. Masson Regnault","doi":"10.1016/j.annder.2023.06.003","DOIUrl":"10.1016/j.annder.2023.06.003","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10025530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hidradenitis suppurativa: Influence of hormonal factors on disease activity in women in France 化脓性汗腺炎:激素因素对法国妇女疾病活动性的影响
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.005
A.-C. Fougerousse , Z. Reguiai , F. Maccari , P. Guillem , J.-L. Perrot , GEM ResoVerneuil
{"title":"Hidradenitis suppurativa: Influence of hormonal factors on disease activity in women in France","authors":"A.-C. Fougerousse , Z. Reguiai , F. Maccari , P. Guillem , J.-L. Perrot , GEM ResoVerneuil","doi":"10.1016/j.annder.2023.06.005","DOIUrl":"10.1016/j.annder.2023.06.005","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10131542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of initial incomplete resection of basal cell carcinoma of the face and neck 面部和颈部基底细胞癌初次不完全切除的预测因素。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.05.002
M. Borg, F. Amatore, J.-M. Foletti, B. Bertrand, N. Macagno, E. Delaporte, M.-A. Richard
{"title":"Predictors of initial incomplete resection of basal cell carcinoma of the face and neck","authors":"M. Borg, F. Amatore, J.-M. Foletti, B. Bertrand, N. Macagno, E. Delaporte, M.-A. Richard","doi":"10.1016/j.annder.2023.05.002","DOIUrl":"10.1016/j.annder.2023.05.002","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41112108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The value of pharmaceutical expertise in the detection and management of drug interactions with targeted therapies in melanoma 药物专业知识在黑色素瘤靶向治疗药物相互作用检测和管理中的价值。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.05.006
B. Demarez, C. Gaudy, F. Amatore, F. Correard, C. Tabèle, M.-A. Richard
{"title":"The value of pharmaceutical expertise in the detection and management of drug interactions with targeted therapies in melanoma","authors":"B. Demarez, C. Gaudy, F. Amatore, F. Correard, C. Tabèle, M.-A. Richard","doi":"10.1016/j.annder.2023.05.006","DOIUrl":"10.1016/j.annder.2023.05.006","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89716614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photodynamic therapy-induced flare of superficial pemphigus 光动力疗法引起的浅表性天疱疮耀斑
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.002
N. Kluger
{"title":"Photodynamic therapy-induced flare of superficial pemphigus","authors":"N. Kluger","doi":"10.1016/j.annder.2023.06.002","DOIUrl":"https://doi.org/10.1016/j.annder.2023.06.002","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138500970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetics of adnexal tumors: An update 附件肿瘤遗传学:最新进展。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.annder.2023.03.003
T. Kervarrec , P. Sohier , D. Pissaloux , A. de la Fouchardiere , B. Cribier , M. Battistella , N. Macagno

Cutaneous adnexal tumors form a vast heterogeneous group that include frequent entities that are mostly benign, as well as rare tumors that are occasionally malignant. In contrast to cutaneous tumors arising from the interfollicular epidermis that develop as a result of accumulation of UV-induced DNA damage (basal cell carcinoma, squamous cell carcinoma), the oncogenesis of adnexal tumors is related to a broad spectrum of genetic mechanisms (e.g., point mutation, fusion genes, viral integration, etc.). In this setting, specific and recurrent genetic alterations have been progressively reported, and these allow better classification of these entities. For certain of them, immunohistochemical tools are now available, enabling precise integrated histological and molecular diagnosis since certain entities are linked to well-defined alterations. In this context, we aim in this review to summarize the main molecular tools currently available for the classification of adnexal tumors.

皮肤附件肿瘤形成了一个庞大的异质性群体,包括常见的良性实体,以及偶尔恶性的罕见肿瘤。与因紫外线诱导的DNA损伤积累而形成的毛囊间表皮皮肤肿瘤(基底细胞癌、鳞状细胞癌)不同,附件肿瘤的发生与广泛的遗传机制有关(如点突变、融合基因、病毒整合等),已经逐渐报道了特定的和反复发生的基因改变,这些改变可以更好地对这些实体进行分类。对于其中的某些实体,现在可以使用免疫组织化学工具,实现精确的组织学和分子综合诊断,因为某些实体与明确的改变有关。在这方面,我们的目的是在这篇综述中总结目前可用于附件肿瘤分类的主要分子工具。
{"title":"Genetics of adnexal tumors: An update","authors":"T. Kervarrec ,&nbsp;P. Sohier ,&nbsp;D. Pissaloux ,&nbsp;A. de la Fouchardiere ,&nbsp;B. Cribier ,&nbsp;M. Battistella ,&nbsp;N. Macagno","doi":"10.1016/j.annder.2023.03.003","DOIUrl":"10.1016/j.annder.2023.03.003","url":null,"abstract":"<div><p>Cutaneous adnexal tumors<span> form a vast heterogeneous group that include frequent entities that are mostly benign, as well as rare tumors that are occasionally malignant. In contrast to cutaneous tumors arising from the interfollicular epidermis<span><span> that develop as a result of accumulation of UV-induced DNA damage (basal cell carcinoma, squamous cell carcinoma), the oncogenesis of adnexal tumors is related to a broad spectrum of genetic mechanisms (e.g., </span>point mutation<span>, fusion genes, viral integration, etc.). In this setting, specific and recurrent genetic alterations have been progressively reported, and these allow better classification of these entities. For certain of them, immunohistochemical tools are now available, enabling precise integrated histological and molecular diagnosis since certain entities are linked to well-defined alterations. In this context, we aim in this review to summarize the main molecular tools currently available for the classification of adnexal tumors.</span></span></span></p></div>","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9622352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice 细胞周期蛋白依赖性激酶CDK4和6抑制剂的皮肤毒性:临床实践的最新综述。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.annder.2022.11.013
V. Sibaud , P. Sollena

Cyclin-dependent kinase (CDK) 4/6 inhibitors (palbociclib, ribociclib and abemaciclib) have revolutionized the treatment of metastatic breast carcinoma. They currently form the first-line treatment, in combination with endocrine agents, for the management of locally advanced or metastatic hormone receptor-positive (HR + ), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, the largest subtype of breast carcinoma.

CDK 4/6 inhibitors have shown comparable efficacy outcomes with predictable and manageable adverse events. In this setting, dermatologic toxicity appears to be relatively frequent, accounting for up to 15% of all reported adverse events. It is usually mild to moderate in intensity and does not normally constitute a dose-limiting toxicity. The range of dermatologic adverse events includes both non-specific entities (maculopapular rash, pruritus, alopecia) and more characteristic toxicities related to CDK4/6 inhibitors, such as vitiligo-like lesions or cutaneous lupus erythematosus. Finally, more severe or life-threatening skin reactions can occasionally occur. The main dermatologic manifestations associated with CDK4/6 inhibitors, as well as management thereof, are described in this comprehensive review.

细胞周期蛋白依赖性激酶(CDK)4/6抑制剂(palbociclib、ribociciclib和abemaciclib)彻底改变了转移性乳腺癌的治疗。目前,它们与内分泌药物联合形成了治疗局部晚期或转移性激素受体阳性(HR + ), 人表皮生长因子受体2阴性(HER2-)乳腺癌症是乳腺癌的最大亚型。CDK4/6抑制剂已显示出可预测和可控制的不良事件的可比疗效结果。在这种情况下,皮肤毒性似乎相对频繁,占所有报告不良事件的15%。它的强度通常为轻度至中度,通常不构成剂量限制毒性。皮肤科不良事件的范围包括非特异性实体(斑丘疹、瘙痒、脱发)和与CDK4/6抑制剂相关的更具特征性的毒性,如白癜风样病变或皮肤红斑狼疮。最后,偶尔会出现更严重或危及生命的皮肤反应。与CDK4/6抑制剂相关的主要皮肤病表现及其管理在本综述中进行了描述。
{"title":"Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice","authors":"V. Sibaud ,&nbsp;P. Sollena","doi":"10.1016/j.annder.2022.11.013","DOIUrl":"10.1016/j.annder.2022.11.013","url":null,"abstract":"<div><p><span>Cyclin-dependent kinase (CDK) 4/6 inhibitors (palbociclib, ribociclib<span> and abemaciclib) have revolutionized the treatment of metastatic </span></span>breast carcinoma<span>. They currently form the first-line treatment, in combination with endocrine agents, for the management of locally advanced or metastatic hormone receptor-positive (HR + ), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, the largest subtype of breast carcinoma.</span></p><p>CDK 4/6 inhibitors have shown comparable efficacy outcomes with predictable and manageable adverse events. In this setting, dermatologic<span> toxicity appears to be relatively frequent, accounting for up to 15% of all reported adverse events. It is usually mild to moderate in intensity and does not normally constitute a dose-limiting toxicity. The range of dermatologic adverse events includes both non-specific entities (maculopapular rash, pruritus, alopecia) and more characteristic toxicities related to CDK4/6 inhibitors, such as vitiligo-like lesions or cutaneous lupus erythematosus<span>. Finally, more severe or life-threatening skin reactions can occasionally occur. The main dermatologic manifestations associated with CDK4/6 inhibitors, as well as management thereof, are described in this comprehensive review.</span></span></p></div>","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10014568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study dupilumab在成人中度至重度特应性皮炎中的实际长期疗效:一项队列研究结果。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.annder.2023.06.004
C. Guédon , M. Tauber , C. Linder , C. Paul , J. Shourick
{"title":"Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study","authors":"C. Guédon ,&nbsp;M. Tauber ,&nbsp;C. Linder ,&nbsp;C. Paul ,&nbsp;J. Shourick","doi":"10.1016/j.annder.2023.06.004","DOIUrl":"10.1016/j.annder.2023.06.004","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10084793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annales De Dermatologie Et De Venereologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1